Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
FDA warning letter
Pharma
China biotech deals, Takeda, LaNova—Fierce Pharma Asia
Biotech deals originating out of China are surging. Takeda touts a pair of OX2R phase 3 wins. Merck's PD-1xVEGF partner is being acquired. And more.
Angus Liu
Jul 18, 2025 9:04am
FDA slams 3 drugmakers for manufacturing infractions
Jul 16, 2025 11:36am
Sprout hit with FDA warning letter over CEO’s Instagram post
Jun 12, 2025 12:00pm
Swedish contract manufacturer hit with FDA warning letter
Jun 9, 2025 9:09am
AACE Pharma slammed with FDA warning letter for CMO’s shortfalls
May 29, 2025 10:11am
Compounder in Lilly lawsuit hit with FDA warning letter
Apr 24, 2025 8:20am
